Get 20% lifetime commission for referring investors to digrin.com
here.
Replimune Group, Inc. ( REPL) - Key Metrics
REPL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | -$0.72 | -$0.78 | -$0.78 |
| 2026Q4 | $0 | -$0.79 | -$0.61 | -$0.61 |
| 2026Q3 | $0 | -$0.77 | -$0.72 | -$0.72 |
| 2026Q2 | $0 | -$0.90 | -$0.88 | -$0.90 |
| 2026Q1 | $0 | -$0.95 | -$0.84 | -$0.87 |
REPL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -3.84 |
| 2026Q4 | 0% | -2.52 |
| 2026Q3 | 0% | -3.16 |
| 2026Q2 | 0% | -1.16 |
| 2026Q1 | 0% | -2.44 |
REPL
Price: $14.63
52 week price:
Earnings Per Share: -3.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 354500
Market Capitalization: 1.4 billion